Literature DB >> 17960482

P450 oxidoreductase deficiency and Antley-Bixler syndrome.

Wiebke Arlt1.   

Abstract

Antley-Bixler syndrome is a congenital malformation syndrome that primarily manifests with craniofacial abnormalities but may include skeletal malformations. Some cases have been shown to be caused by fibroblast growth factor receptor 2 mutations and, recently, it was revealed that others are caused by mutations in the electron donor enzyme P450 oxidoreductase (POR). P450 oxidoreductase deficiency, however, is not only associated with the malformations but frequently presents with disordered sex development in affected patients of both sexes. Furthermore, biochemical work-up invariably reveals impairment of 17-hydroxylase and 21-hydroxylase activities, two steroidogenic enzymes dependent on electron transfer from POR. While we begin to gain insight into the pathogenesis of disease, detailed genotype-phenotype studies are still lacking and POR deficiency presents several challenges for research. Firstly, the exact pathogenesis of the skeletal malformations as a consequence of POR mutations is unclear, though impaired sterol biosynthesis has been implicated. Secondly, it needs to be explained, why the external genitalia in affected boys may appear undervirilized while affected girls can be severely virilized. Further evidence is required for the proposed alternative pathway in human androgen synthesis that might explain the apparently contradictory finding of low circulating androgens and severely virilised external genitalia in affected girls. Recent studies have provided evidence for a differential interaction of specific POR mutations with different electron-accepting P450 enzymes and this may provide the key for further understanding of the complex pathogenesis of this complex disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960482     DOI: 10.1007/s11154-007-9056-y

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  38 in total

Review 1.  Novel lipid modifications of secreted protein signals.

Authors:  Randall K Mann; Philip A Beachy
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

2.  Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?

Authors:  W Reardon; A Smith; J W Honour; P Hindmarsh; D Das; G Rumsby; I Nelson; S Malcolm; L Adès; D Sillence; D Kumar; C DeLozier-Blanchet; S McKee; T Kelly; W L McKeehan; M Baraitser; R M Winter
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient.

Authors:  K A Aleck; D L Bartley
Journal:  Am J Med Genet       Date:  1997-10-31

4.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

5.  A male patient presenting with major clinical symptoms of glucocorticoid deficiency and skeletal dysplasia, showing a steroid pattern compatible with 17alpha-hydroxylase/17,20-lyase deficiency, but without obvious CYP17 gene mutations.

Authors:  M Adachi; K Tachibana; Y Asakura; S Suwa; G Nishimura
Journal:  Endocr J       Date:  1999-04       Impact factor: 2.349

6.  Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.

Authors:  E W Jabs; X Li; A F Scott; G Meyers; W Chen; M Eccles; J I Mao; L R Charnas; C E Jackson; M Jaye
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

7.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.

Authors:  A O Wilkie; S F Slaney; M Oldridge; M D Poole; G J Ashworth; A D Hockley; R D Hayward; D J David; L J Pulleyn; P Rutland
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

8.  Fluconazole-induced congenital anomalies in three infants.

Authors:  T J Pursley; I K Blomquist; J Abraham; H F Andersen; J A Bartley
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

9.  Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.

Authors:  W Reardon; R M Winter; P Rutland; L J Pulleyn; B M Jones; S Malcolm
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

10.  Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P.

Authors:  Vivek Dhir; Hannah E Ivison; Nils Krone; Cedric H L Shackleton; Aidan J Doherty; Paul M Stewart; Wiebke Arlt
Journal:  Mol Endocrinol       Date:  2007-05-15
View more
  5 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients.

Authors:  Chengxian Guo; Q I Pei; Hongyi Tan; Zhijun Huang; Hong Yuan; Guoping Yang
Journal:  Biomed Rep       Date:  2014-12-02

4.  Effects of thyroxine exposure on osteogenesis in mouse calvarial pre-osteoblasts.

Authors:  James J Cray; Kameron Khaksarfard; Seth M Weinberg; Mohammed Elsalanty; Jack C Yu
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

5.  Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children.

Authors:  Lijun Fan; Xiaoya Ren; Yanning Song; Chang Su; Junfen Fu; Chunxiu Gong
Journal:  Orphanet J Rare Dis       Date:  2019-12-30       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.